Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HORIZON 1: Ad26.COV2.S in Healthy Pregnant Participants
NCT04765384Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2021
- Primary completion
- Nov 2023
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of Ad26.COV2.S in coronavirus disease 2019 (COVID-19), sponsored by Janssen Pharmaceutical. Started Aug 2021; status: completed.
02
Drugs
Ad26.COV2.S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04765384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04765384.